TRON Group Revenue
Pharmaceutical Manufacturing • • 1-10 Employees
$
TRON Group revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at TRON Group
Christopher Deigl
Member Board of Directors
Company overview
| Headquarters | XX |
| Websites | |
| NAICS | 3254 |
| Founded | 2015 |
| Employees | 1-10 |
| Socials |
About TRON Group
TRON Group Inc. (OTC: TGRP), through its subsidiaries, is a clinical-stage specialty pharmaceutical company developing oral, topical, and injectable products for cancer, central nervous system (CNS) disorders, and infectious diseases. TRON Group Inc. subsidiaries include Nanopharmaceutics, Inc., a wholly-owned subsidiary, and Alchem Laboratories Corporation, a majority-owned subsidiary, both located in Alachua, Florida.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Director
Funding Data
TRON Group has never raised funding before.
United Arab Emirates
Canada
Italy
PolandFrequently asked questions
TRON Group is located in XX.
TRON Group generates an estimated annual revenue of $85,555. This revenue figure reflects the company's market position and business performance in its industry.
TRON Group has an estimated valuation of $273,776. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
TRON Group was founded in 2015, making it 11 years old. The company has established itself as a significant player in its industry over this time.
TRON Group has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
